{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:58:18Z","timestamp":1792785498614,"version":"4.5.0"},"reference-count":136,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"University of Sydney","id":[{"id":"https:\/\/ror.org\/0384j8v12","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Delivery"],"DOI":"10.1080\/17425247.2026.2751858","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T05:15:07Z","timestamp":1792386907000},"page":"1-21","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Respiratory drug delivery: physiological, technical, and regulatory considerations for dissolution testing of orally inhaled dry powder aerosols"],"prefix":"10.1080","author":[{"given":"Zhengqi","family":"Xu","sequence":"first","affiliation":[{"name":"The University of Sydney","place":["Sydney, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhimata","family":"Paramanandana","sequence":"additional","affiliation":[{"name":"Universitas Airlangga","place":["Surabaya, Indonesia"]},{"name":"Universitas Airlangga","place":["Surabaya, Indonesia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7054-3137","authenticated-orcid":false,"given":"Hak-Kim","family":"Chan","sequence":"additional","affiliation":[{"name":"The University of Sydney","place":["Sydney, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1089\/089426803772455622"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781118799536.ch1"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/15287398409530496"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-53856-7.00006-3"},{"key":"e_1_3_5_7_1","first-page":"21","volume-title":"Pulmonary drug metabolism, clearance, and absorption. Controlled pulmonary drug","author":"Olsson B","year":"2011","unstructured":"Olsson B, Bondesson E, Borgstr\u00f6m L, et al. Pulmonary drug metabolism, clearance, and absorption. Controlled pulmonary drug. Delivery: Springer; 2011. p. 21\u201350."},{"issue":"1","key":"e_1_3_5_8_1","first-page":"5","article-title":"Pulmonary surfactants and their role in pathophysiology of lung disorders","volume":"51","author":"Akella A","year":"2013","unstructured":"Akella A, Deshpande SB. Pulmonary surfactants and their role in pathophysiology of lung disorders. Indian J Exp Biol. 2013;51(1):5\u201322.","journal-title":"Indian J Exp Biol"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00181"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1089\/jam.1992.5.179"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2014.05.017"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-815720-6.00001-0"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0185(20000215)261:1<25::AID-AR6>3.0.CO;2-7"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aew435"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02683.x"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.119009"},{"issue":"6","key":"e_1_3_5_17_1","first-page":"18","article-title":"The lung as a dissolution vessel","volume":"8","author":"Hastedt J","year":"2014","unstructured":"Hastedt J. The lung as a dissolution vessel. Inhalation. 2014;8(6):18\u201322.","journal-title":"Inhalation"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122667"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10040259"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp500210c"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00524"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.102318299"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1988.64.3.1273"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.2012.01523.x"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.31035"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.3c01170"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/frmbi.2023.1192316"},{"key":"e_1_3_5_28_1","first-page":"247","volume-title":"Comparative interpretation of ct and standard radiography of the chest","author":"De Wever W","year":"2010","unstructured":"De Wever W. The respiratory tract. In: Coche EE, Ghaye B, Mey J, et al., editors. Comparative interpretation of ct and standard radiography of the chest. Berlin, Heidelberg: Springer; 2010. p. 247\u2013268."},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.154.6.8970383"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1990.69.4.1302"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201411-507FR"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1529\/biophysj.106.102681"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp1002448"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2021.0006"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cocis.2018.01.001"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.24530"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2017.11.001"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-025-01575-4"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.241108"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2024-222444"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0910061"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1021\/ed047p261"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00419-2019"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122661"},{"issue":"1","key":"e_1_3_5_45_1","first-page":"48","article-title":"An advanced stochastic model for mucociliary particle clearance in cystic fibrosis lungs","volume":"4","author":"Sturm R","year":"2012","unstructured":"Sturm R. An advanced stochastic model for mucociliary particle clearance in cystic fibrosis lungs. J Thorac Dis. 2012;4(1):48.","journal-title":"J Thorac Dis"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00010.2024"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-3402495"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-004-2511-6"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2014.02.009"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-13-11"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.05.015"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781118799536.ch10"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5193(86)80098-4"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-16822-8"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.842592"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028241"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12989-024-00591-9"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.9297121"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2406294121"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.26.2.479-486.1979"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0927-7765(02)00042-5"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060989"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2005-0373OC"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2004.08.001"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.9297153"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2014.02.001"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2023.2205636"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-020-0422-y"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.60565\/CARR-RF93"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-025-03860-0"},{"key":"e_1_3_5_71_1","first-page":"6","volume-title":"Respiratory Drug Delivery Conference","author":"Xu Z","year":"2026","unstructured":"Xu Z, Khanal D, Bielski E, et al. Use of a modified next generation impactor and Franz cell for characterization of the in vitro dissolution performances of innovator and generic dry powder inhalers. In: Respiratory Drug Delivery Conference; Scottsdale, (AZ), USA 2026; 2026. p. 6."},{"key":"e_1_3_5_72_1","first-page":"6","volume-title":"Respiratory Drug Delivery Conference 2026","author":"Xu Z","unstructured":"Xu Z, Khanal D, Bielski E, et al. Combination of a newly developed modified next generation impactor and Franz cell method for in vitro dissolution characterization of inhalation powders: development and validation. In: Respiratory Drug Delivery Conference 2026; Scottsdale, (AZ), USA2026. p. 6."},{"key":"e_1_3_5_73_1","unstructured":"Shah VP Smurthwaite MJ Veranth JM. The inhalation ad hoc advisory panel for the usp performance tests of inhalation dosage forms. USA: The United States Pharmacopeial Convention Inc.; 2008."},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030983"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-012-0744-2"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600570832"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2006.07.006"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-015-0283-3"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20994"},{"key":"e_1_3_5_80_1","unstructured":"USP GC. <711> Dissolution. United States Pharmacopeia. 2011."},{"key":"e_1_3_5_81_1","first-page":"19","volume-title":"Pharmaceutical dissolution testing","author":"Kramer J","year":"2005","unstructured":"Kramer J. Historical development of dissolution testing. In: Kramer J, Dressman J, editors. Pharmaceutical dissolution testing. Boca Raton: CRC Press; 2005. p. 19\u201356."},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16091157"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2008.04.009"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.14227\/DT170210P6"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2009.07.034"},{"key":"e_1_3_5_86_1","unstructured":"May S. Dissolution testing of powders for inhalation. 2013."},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.14227\/DT180411P46"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.14227\/DT120205P23"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(03)00091-7"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1080\/01932691.2023.2188923"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.5b00221"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-015-9848-z"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.14227\/DT220315P40"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-010-9522-9"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.2c00177"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13101541"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1089\/adt.2017.779"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.2c00113"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120893"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.5599\/admet.2861"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/1520-6017(200101)90:1<98::AID-JPS11>3.0.CO;2-5"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-85146-6.00029-2"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2021.1882991"},{"key":"e_1_3_5_104_1","unstructured":"Bastola R. In vitro model to assist inhaled product development. University of Otago; 2023."},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1002\/smsc.202100067"},{"issue":"3","key":"e_1_3_5_106_1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s004670000437","article-title":"Gamble and Darrow: pathfinders in body fluid physiology and fluid therapy for children, 1914\u20131964","volume":"15","author":"Holliday MA","year":"2000","unstructured":"Holliday MA. Gamble and Darrow: pathfinders in body fluid physiology and fluid therapy for children, 1914\u20131964. Pediatr Nephrol. 2000;15(3):317\u2013324.","journal-title":"Pediatr Nephrol"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph14020112"},{"issue":"12","key":"e_1_3_5_108_1","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1007\/s11095-017-2169-4","article-title":"A biocompatible synthetic lung fluid based on human respiratory tract lining fluid composition: Kumar et al","volume":"34","author":"Kumar A","year":"2017","unstructured":"Kumar A, Terakosolphan W, Hassoun M, et al. A biocompatible synthetic lung fluid based on human respiratory tract lining fluid composition: Kumar et al. Pharm Res. 2017;34(12):2454\u20132465.","journal-title":"Pharm Res"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2018.08.006"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.14227\/DT260219P6"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-024-03696-0"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-022-03270-6"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-014-1413-4"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.0c00163"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-014-9615-6"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-6426-0_11"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.5510\/OGP20250101052"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1080\/10543406.2023.2171429"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-022-00697-y"},{"key":"e_1_3_5_120_1","unstructured":"Mandula H. Rational statistical analysis practice in dissolution profile comparison: FDA perspective. Vitro dissolution profiles similarity assessment in support of drug product quality: what how and when Baltimore MD2019. 2019."},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13101703"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.14227\/DT200113P13"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-025-03937-w"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-015-9787-8"},{"key":"e_1_3_5_125_1","unstructured":"Draft guidance on Fluticasone Propionate. U.S. America: FDA; 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/psg\/PSG_020833.pdf"},{"key":"e_1_3_5_126_1","unstructured":"Draft guidance on Formoterol Fumarate; Mometasone Furoate. U.S. America: FDA; 2026. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/psg\/PSG_022518.pdf"},{"key":"e_1_3_5_127_1","unstructured":"Draft guidance on Budesonide; Formoterol Fumarate Dihydrate. U.S. America: FDA; 2026. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/psg\/PSG_021929.pdf"},{"key":"e_1_3_5_128_1","unstructured":"Draft guidance on Budesonide; Formoterol Fumarate; Glycopyrrolate. U.S. America: FDA; 2026. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/psg\/PSG_212122.pdf"},{"key":"e_1_3_5_129_1","unstructured":"Draft guidance on Ciclesonide. U.S. America: FDA; 2026. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/psg\/PSG_021658.pdf"},{"key":"e_1_3_5_130_1","unstructured":"Draft guidance on Fluticasone Propionate. U.S. America: FDA; 2026. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/psg\/PSG_021433.pdf"},{"key":"e_1_3_5_131_1","unstructured":"Draft guidance on Fluticasone Propionate; Salmeterol Xinafoate. U.S. America: FDA; 2026. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/psg\/PSG_021254.pdf"},{"key":"e_1_3_5_132_1","unstructured":"Draft guidance on Budesonide; Formoterol Fumarate. U.S. America: FDA; 2026. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/psg\/PSG_216579.pdf"},{"key":"e_1_3_5_133_1","unstructured":"Draft guidance on Beclomethasone Dipropionate. U.S. America: FDA; 2026. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/psg\/PSG_020911.pdf"},{"key":"e_1_3_5_134_1","unstructured":"Draft guidance on Albuterol Sulfate; Budesonide. U.S. America: FDA; 2026. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/psg\/PSG_214070.pdf"},{"key":"e_1_3_5_135_1","unstructured":"Draft guidance on Mometasone Furoate. U.S. America: FDA; 2026. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/psg\/PSG_205641.pdf"},{"key":"e_1_3_5_136_1","doi-asserted-by":"publisher","DOI":"10.3109\/03639040903092319"},{"key":"e_1_3_5_137_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-015-9733-9"},{"key":"e_1_3_5_138_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.3c00685"}],"container-title":["Expert Opinion on Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2026.2751858","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17425247.2026.2751858","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2026.2751858","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T05:58:40Z","timestamp":1792562320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425247.2026.2751858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":136,"alternative-id":["10.1080\/17425247.2026.2751858"],"URL":"https:\/\/doi.org\/10.1080\/17425247.2026.2751858","relation":{},"ISSN":["1742-5247","1744-7593"],"issn-type":[{"value":"1742-5247","type":"print"},{"value":"1744-7593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-08-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}